Key terms
About LAB
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LAB news
Mar 18
9:22am ET
Standard BioTools Streamlines Structure and Strengthens Governance
Mar 18
8:19am ET
Standard BioTools announces exchange of all oustanding Series B Preferred stock
Feb 28
4:25pm ET
Standard BioTools Projects Positive Outlook for 2024
Feb 26
8:11am ET
Standard BioTools, NGD partner for automation of pathogen sequencing
Feb 07
8:31am ET
Standard BioTools, Navignostics announce collaboration agreement
Jan 19
5:09pm ET
Standard BioTools files to sell 38.43M shares of common stock for holders
Jan 08
8:49am ET
Standard BioTools sees FY23 revenue $106M
Jan 08
8:49am ET
Standard BioTools sees Q4 revenue approximately $28M
Jan 05
8:50am ET
Standard BioTools trading halted, news dissemination
Jan 05
8:48am ET
Standard BioTools completes merger with SomaLogic
Jan 05
5:31am ET
SomaLogic shareholders approve transaction with Standard BioTools
Jan 05
5:23am ET
Standard BioTools shareholders approve SomaLogic merger
Jan 04
10:56pm ET
Standard BioTools shareholders approve SomaLogic merger
Dec 29
4:54pm ET
SomaLogic announces Glass Lewis, ISS recommendation for Standard BioTools merger
Dec 29
9:07am ET
SomaLogic sent letter to stockholders on transaction with Standard BioTools
Dec 26
4:10pm ET
SomaLogic corrects ‘Madryn Asset Management’s misleading disclosure’
Dec 26
9:22am ET
SomaLogic shareholder says company ran ‘incomplete’ review of alternatives
Dec 22
7:00pm ET
ISS urges Standard BioTools holders vote ‘FOR’ proposed merger with SomaLogic
Dec 22
6:52pm ET
ISS urges SomaLogic shareholders vote ‘FOR’ proposed merger with Standard BioTools
Dec 22
8:37am ET
SomaLogic shareholder comments on disclosures related to Standard BioTools deal
Dec 21
8:08am ET
SomaLogic urges stockholders to vote for Standard BioTools merger
Dec 21
7:43am ET
Madryn issues letter to holders correcting SomaLogic statements in presentation
Dec 21
7:36am ET
Madryn issues letter to holders correcting SomaLogic statements in presentation
Dec 20
9:23am ET
Skye Fund III issues letter regarding opposition of SomaLogic’s proposed merger
No recent news articles are available for LAB
No recent press releases are available for LAB
LAB Financials
Key terms
Ad Feedback
LAB Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LAB Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range